Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B
Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B Professional…
Lucid Diligence Brief: Kardigan $254m Series B
Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia
Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia…
Lucid Diligence Brief: EVOQ x Sanofi collaboration
Lucid Diligence Brief: EVOQ x Sanofi collaboration Professional audiences only.…
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040
Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional…
Lucid Diligence Brief: Verily UCHealth AI collaboration
Lucid Diligence Brief: Verily UCHealth AI collaboration Professional audiences…
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…
Lucid Diligence Brief: Excellergy ECRIs, $70M investment
Lucid Diligence Brief: Excellergy ECRIs, $70M investment Professional audiences…
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI Professional audiences…
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close Professional…
Neuroscience Weekly News - October 8th 2025
🧠 This Week in Neuroscience: China’s Nerivio Nod, Ocrevus in Pediatric MS,…
Endocrinology Weekly Update - October 7th 2025
Endocrinology Update: Isturisa dosing model, YAP–T1D link, Mounjaro expansion…